Search results
- Clinical inertia is defined as lack of treatment intensification in a patient not at evidence-based goals for care. Clinical inertia is a major factor that contributes to inadequate chronic disease care in patients with diabetes mellitus, hypertension, dyslipidemias, depression, coronary heart disease, and other conditions.
www.ncbi.nlm.nih.gov/books/NBK20513/
People also ask
What is clinical inertia?
What is clinical inertia in Diabetology?
Can clinical guidelines overcome clinical inertia?
What is apparent clinical inertia?
Which patient-related factors favor clinical inertia?
What causes clinical inertia?
Therapeutic inertia (also known as clinical inertia [1]) is a measurement of the resistance to therapeutic treatment for an existing medical condition. It is commonly measured as a percentage of the number of encounters in which a patient with a condition received new or increased therapeutic treatment out of the total number of visits to a ...
Clinical inertia is a major factor that contributes to inadequate chronic disease care in patients with diabetes mellitus, hypertension, dyslipidemias, depression, coronary heart disease, and other conditions.
- Patrick J. O'Connor, Jo Ann M. Sperl-Hillen, Paul E. Johnson, William A. Rush, George R Biltz
- 2005/02
- 2008
Feb 1, 2020 · Therapeutic inertia is a common occurrence in the care of people with diabetes and impairs the ability of patients with diabetes to attain and maintain glycemic targets, which in turn increases risks for the development and progression of diabetes-related complications.
Aug 28, 2023 · Clinical inertia is commonly described in asymptomatic chronic disease, but if we analyse various clinical scenarios, it is clear that clinical inertia occurs in acute and chronic illnesses, infectious and non-infectious conditions, and symptomatic and asymptomatic conditions [Table 1].
- Arkiath Veettil Raveendran
- Jul-Aug 2023
- 10.4103/ijem.ijem_119_23
- Box 1—Defining Clinical Inertia in Diabetes Care
- Box 2—The Other Face of Inertia
- Box 3—Epidemiology of Clinical Inertia in Diabetes Care
- Box 4—How Can We Overcome The Barriers of Clinical Inertia?
The discrepancy between Guidelines and clinical practice is defined in the literature as “clinical inertia” or “therapeutic inertia”. Although these terms are usually employed in diabetology to indicate the lack of insulin initiation, according to Khunti and Davies the concept of inertia can be extended throughout the natural history of diabetes f...
When talking about therapeutic inertia, overtreatment (usually of elderly people) and “failure to de-intensify diabetes therapy” cannot be overlooked, since they constitute “the other face” of inertia and a large problem in diabetes care . Overtreatment is defined by the Institute of Medicine as the use of a treatment even when the potential harms ...
Inertia relating to diabetes management has been reported for over a decade with Shah and colleagues showing that less than half of a Canadian cohort of 2502 patients with type 2 diabetes and high HbA1c had received intensification of their treatment in 2005 . In 2011 Fu and colleagues demonstrated a median time to intensification of treatment of 1...
Health professionals-related barriers It is fundamental to identify the subjects at higher risk of delay in the intensification of the treatments . Several studies have documented that active feedback to healthcare professionals and the introduction of specific informatic remainders are able to reduce the time of therapeutic intensification . Proac...
- F. Andreozzi, R. Candido, S. Corrao, R. Fornengo, A. Giancaterini, P. Ponzani, M. C. Ponziani, F. Tu...
- 2020
Jan 5, 2009 · Physician inertia is defined as the failure to initiate therapy or to intensify or change therapy in patients with BP values >140/90 mm Hg, or >130/80 mm Hg in hypertensive patients with diabetes, renal, or coronary heart disease.
Aug 10, 2018 · Clinical inertia is defined as a failure to intensify therapy appropriately when treatment goals have not been met. A recent study by Pantalone, et al found high rates of clinical inertia among patients with type 2 diabetes mellitus (T2DM) being treated at the Cleveland Clinic.
